Evaluation of the safety profiles of estrogenic Chinese herbal medicines in breast cancer

ConclusionThe considerable concerns on the use of CD and DO in breast cancer patients could be relieved to some extents upon the findings of this pre-clinical study. The potential harmful effects of estrogenic Chinese herbal medicines on breast cancer growth should be verified in both cell-based and tumor-bearing mice models.Graphical abstract
Source: Phytomedicine - Category: Drugs & Pharmacology Source Type: research